Acute Heart Failure
Conditions
Keywords
acute heart failure
Brief summary
During the last decade, progress has been made in the management of heart failure. However, the changing characteristics of patients and practices in the real world and their impact on the prognosis of patients admitted for acute heart failure remain poorly studied. 2000 consecutive patients recruited in a single day in hospitals volunteered to participate in the cohort during a day dedicated.
Detailed description
The total duration of recruitment is one day (date to be set soon by the Executive Committee): all patients hospitalized, and whatever their date of admission with the diagnosis of heart failure will be selected for the study. Information on each hospital stay will be obtained at baseline and at the end of the hospitalization by the hospital teams. A telephone follow-up will be conducted at 3 months among survivors and / or their doctor by CRAs dedicated to the French Society of Cardiology.
Interventions
None listed
Sponsors
French Cardiology Society
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Male or female age (e) over 18 years 2. Inpatient, whatever the mode of initial admission with acute heart failure (de novo heart failure or decompensation of chronic heart failure) regardless of severity, corresponding to one of the following clinical situations (clinical criteria in Appendix 1): * Pulmonary edema, hypertensive or not * congestive heart failure (pulmonary congestion and peripheral edema) * cardiogenic shock * Insufficient high output cardiac 3. Patients who agreed to participate in the study 4. Isolated right heart failure
Exclusion criteria
1. expressed refusal to participate in the study 2. Hospitalization scheduled for review 3. Background surgery (immediate postoperative period) 4. Diagnosis of acute heart failure reversed in favor of an alternative diagnosis before discharge from hospital
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Survival at 3 months | 3 months | Analyze survival 3 months after the end of initial hospitalization |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patterns of admission | 3 months | Analyze patterns of admission and discharge of patients, depending on their characteristics |
| Co-morbidities | 3 months | Analyze the co-morbidities and their impact on care and survival |
| Drug treatments | 3 months | Analyze the evolution of drug treatment between the output and monitoring to 3 months |
| Hospital Methods | 3 months | Compare methods of care based on clinical characteristics and hospital structures. |
| Therapeutic resources | 3 months | Analyze the use of therapeutic resources based on specific clinical features: intensive care, ventilation, inotropes, ultrafiltration, introduction of beta-blockers, stimulation, implantable cardioverter defibrillator, circulatory support, graft |
| During of stay | 3 months | Analyze the duration of stay according to clinical characteristics. |
| Resources specific diagnostic | 3 months | Analyze the use of resources specific diagnostic: measurement of BNP or NTproBNP, conducting echocardiogram, coronary angiography, Holter-ECG, Cardiac MRI, Cardiac CT |
Countries
France
Outcome results
None listed